Jonathan C. Howell, MD, PhD, is board certified in both pediatrics and pediatric endocrinology. He has been on the faculty of Cincinnati Children’s Hospital Medical Center within the Department of Pediatrics of the University of Cincinnati College of Medicine since 2012.
Dr. Howell is an assistant professor of pediatrics in the Division of Endocrinology within the UC Department of Pediatrics. His main clinical focus is diabetes as well as providing care for patients with endocrine disorders, including growth, thyroid, pituitary, pubertal, and adrenal dysfunction. Dr. Howell’s research focuses on the effects of congenital anemias and cancer on the endocrine system and the outcomes of chemotherapy, radiation, transfusions, and chronic steroid therapy on endocrine hormone function.
Dr. Howell received his Bachelor of Arts degree from Hanover College. He received his PhD from Indiana University and his MD from Indiana University School of Medicine.
Dr. Howell completed his pediatric internship and residency at Cincinnati Children’s Hospital Medical Center, where he also served as chief resident. He also obtained his fellowship training from Cincinnati Children’s.
BA: Hanover College, Hanover, IN, 1997.
PhD: Indiana University (Edward F. Srour, thesis adviser), Indianapolis, IN, 2003.
MD: Indiana University School of Medicine, Indianapolis, IN, 2005.
Residency: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2005-2008.
Chief Residency: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2008-2009.
Endocrinology Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2009-2012
Certification: Pediatrics, 2008; Pediatric Endocrinology, 2013.
Endocrinology, Rasopathy, Differences of Sex Development
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Bone Health Outcomes at 1 Year after Hematopoietic Stem Cell Transplantation in a Heterogeneous Pediatric Population. Transplantation and cellular therapy. 2022; 28:44.e1-44.e6.
Incidence of thyroid dysfunction in children after HSCT with reduced intensity conditioning (RIC) or myeloablative conditioning (MAC). Pediatric Transplantation. 2021; 25.
SUN-065 Bone Health Outcomes in a Large, Diverse Pediatric Cohort Undergoing Hematopoietic Stem Cell Transplant. Journal of the Endocrine Society. 2020; 4:sun-065.
Pituitary disease in pediatric brain tumor survivors. Expert Review of Endocrinology and Metabolism. 2019; 14:283-291.
Single Ultra-High-Dose Cholecalciferol to Prevent Vitamin D Deficiency in Pediatric Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2018; 24:1856-1860.
Reduced Fertility Potential in Young Patients Following Hematopoietic Stem Cell Transplantation Despite Reduced Intensity Conditioning. Journal of Pediatric and Adolescent Gynecology. 2018; 31.
88 Reduced Fertility Potential in Young Patients Following Hematopoietic Stem Cell Transplantation Despite Reduced Intensity Conditioning. Biology of Blood and Marrow Transplantation. 2018; 24:s89-s90.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey